Quick Summary
Vinbix 10mg Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹1836
MRP: ₹3375
(You Save ₹1539)
1 VIAL(s)
46% OFF
₹1836
MRP: ₹3,375.00
Inclusive of all taxes
46% Off
Substitutes
Vinelbine 10mg Injection
FRESENIUS KABI ...
₹ 2029.00/injection
11% costlier
Vinrel 10mg Injection
KHANDELWAL LABO...
₹ 2070.00/injection
13% costlier
Navelbine 10mg Injection
ABBOTT
₹ 3180.00/injection
74% costlier
Neoben 10mg Injection
NEON LABORATORI...
₹ 849.00/injection
53% cheaper
Introduction to Vinbix 10mg Injection
Vinbix 10mg Injection is a chemotherapy medication containing the active constituent Vinorelbine. It belongs to the group of medications known as vinca alkaloids. It is indicated to treat non-small cell lung cancer and breast cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. This medication is not recommended for adolescents and children under 18 years of age.
The common side effects that are likely to associate with Vinorelnine are nausea, vomiting, low blood cell counts, tiredness, weakness, hair loss, pain in the jaws, joints and muscles, diarrhea, swelling or sores in the throat or mouth and injection site reactions (redness, burning pain, vein discoloration). Inform your physician if these side effects disturb or persist in you.
Report to your doctor if you are allergic to Vinorelbine and its ingredients. While taking Vinbix 10mg Injection, Inform your physician if you have any signs or symptoms of infection (cough, fever, chills, or joint pain), severe chest pain, history of heart attack, or liver disorders.
Before and during treatment with this medication, your physician will check the blood cell count. Use effective birth control during the treatment and at least three months after the final dose. Inform your physician about all the medicines you are taking including herbal medicines and supplements. Many vaccines (live attenuated vaccines) are not recommended during this treatment. Consult your healthcare professional if you have recently received any vaccines or require any.
Uses of Vinbix 10mg Injection
- Non-small cell lung cancer (NSCLC)
- Breast cancer
Therapeutic Effects of Vinbix 10mg Injection
Vinbix 10mg Injection works by inhibiting the microtubule structures within the cell. Microtubule structures help cancer cells to divide and multiply. Inhibition of these structures slows the growth and multiplication of cancer cells.
Interaction of Vinbix 10mg Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements and herbal products that you are taking or have taken before the treatment. Certain medications tends to interact with Vinbix 10mg Injection and can cause undesirable side effects.
More Information about Vinbix 10mg Injection
- Keep Vinbix 10mg Injection out of sight and reach of children.
- Store in a refrigerator (2°C to 8°C).
How to consume Vinbix 10mg Injection
This medication is administered into a vein by your healthcare provider. The dose and duration is decided by your physician.
Safety Advice for Vinbix 10mg Injection
Breast Feeding
It is not recommended for breastfeeding while taking Vinbix 10mg Injection. Consult your doctor for further details.
Alcohol
It is unknown whether it is safe to consume alcohol with Vinbix 10mg Injection. Consult your doctor for advice.
Liver
Inform your physician if you have any liver disorders before taking Vinbix 10mg Injection as this medication should be used with caution in liver disease patients.
Lungs
Vinbix 10mg Injection is safe to use in patients with lung disease. Inform your doctor if you have any underlying lung disease.
Driving
Vinbix 10mg Injection may cause side effects that could impair your driving ability. Avoid driving if you are unwell.
Pregnancy
Vinbix 10mg Injection is unsafe to use during pregnancy as it may harm the unborn baby. Women should use effective contraception during and after the 3 months of treatment.
Side Effects of Vinbix 10mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Severe allergic reactions (rash, difficulty in breathing, swelling of eyelids, lips, face, or throat)
- Severe chest pain
- Severe low blood pressure (severe dizziness, lightheadedness when you stand up)
- Severe constipation with abdominal pain
- Major infection (cough, fever, chills)
Common
- Nausea, vomiting
- Low blood cell counts, weakness
- Hair loss
- Swelling or sores in the throat or mouth
- Injection site reactions (redness, burning pain, vein discoloration)
- Pain in the jaws, joints and muscles
- Tiredness
- Diarrhea
Word of Advice
It is suggested that women should use effective birth control for at least three months before starting and during treatment with Vinbix 10mg Injection. Male patients are advised to use effective contraception during therapy and three months after treatment to avoid fathering children. Before receiving Vinbix 10mg Injection treatment, male patients should get advice on sperm conservation. Your doctor may take regular blood tests to monitor your blood cell count, platelet count and liver function.
FAQs about Vinbix 10mg Injection
Q1.
Can I take vaccinations while taking Vinbix 10mg Injection?
No, you should not get vaccinated with "live" or "attenuated" vaccinations, like the yellow fever vaccine, as it may cause severe adverse effects. Hence, without consulting your healthcare provider, this medication should not be taken with any vaccinations.
Q2.
Can children use Vinbix 10mg Injection?
No, Vinbix 10mg Injection is not recommended for usage in children.
Q3.
Is it safe to become a father while taking Vinbix 10mg Injection?
It is unsafe to become a father during and three months after treatment. Hence, effective contraceptives must be used and get advice on sperm conservation before Vinoreline treatment. Because it may alter male fertility.
Q4.
Who is contraindicated to taking Vinbix 10mg Injection?
Patients with severe kidney problems, low blood cells, low platelet, severe infection, pregnant and breastfeeding mothers should not use Vinbix 10mg Injection. It is also not recommended for patients who are allergic to Vinbix 10mg Injection and its ingredients.
Fact Box of Vinbix 10mg Injection
Molecule name: Vinorelbine | Therapeutic class: Antineoplastics |
Pharmacological class: Vinca alkaloids | Indications: 1. Non-small cell lung cancer (NSCLC) 2. breast cancer |
References
- Pierre Fabre Limited, Electronic medicines compendium (EMC), [Revised on Nov 2022] [ Accessed on 1st Dec 2022], https://www.medicines.org.uk/emc/files/pil.3912.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1706.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
- Pierre Fabre Medicament, US Food and Drug administration, [Revised on Jan 2022] [ Accessed on 1st Dec 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020388s037lbl.pdf
- Anna Capasso; Vinorelbine in Cancer therapy; Cancer Drug Targets; Published on July 2012; Accessed on 01/12/2022; https://pubmed.ncbi.nlm.nih.gov/22594474/
- Ying-Chun Xu et al; A systematic review of vinorelbine for the treatment of breast cancer; The Breast Journal; Published on April 2013; Accessed on 01/12/2022; https://pubmed.ncbi.nlm.nih.gov/23320984/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Ishwarya R.
M.Sc.
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
